Skip to content

Author

Yu-Chen Li

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Large language models to support oncology symptom telephone triage: A retrospective pre-implementation evaluation.

672 Background: Oncology symptom telephone triage is an essential supportive care service for patients with cancer, providing assessment and guidance for symptoms outside scheduled visits. Rising call volumes and clinical complexity create a need for tools that improve timeliness, consistency, and documentation...

L. Thanabalachandran, Maitha Al Sibani, S. Marshall et al. · 0 citations
Open access Oct 2026

Adoption and practice variation of DPYD genotyping prior to fluoropyrimidine therapy at two Canadian cancer centres.

528 Background: Fluoropyrimidines are widely used in the treatment of solid malignancies. Variants in the dihydropyrimidine dehydrogenase ( DPYD ) gene increase the risk of severe fluoropyrimidine-associated toxicity. Following guidance from Ontario Health (Cancer Care Ontario) recommending DPYD genotyping...

Sara Ladak, L. Thanabalachandran, Alisia Chen et al. · 0 citations
Review Open access Oct 2026

Optimizing colorectal cancer NGS pathways: Quality gaps, workflow barriers, and digital/AI readiness.

181 Background: Next-generation sequencing (NGS) is integral to colorectal cancer care, as expanding targeted therapies depend on timely molecular profiling. However, timely processing and access to results depend on a multistep pathway, including biopsy, pathologist review, test initiation, laboratory processi...

L. Thanabalachandran, D. Ali, Avery Newman-Simmons et al. · 0 citations
Review Open access Sep 2026

Assessing Quality Gaps and Clinician Perspectives on AI Integration in Colorectal Cancer NGS Pathways

Simple Summary For people with advanced colorectal cancer, choosing the most effective treatment depends on timely genetic testing of the tumour. When these results are delayed or hard to access, treatment may be postponed or started before the best targeted option is known. Because this testing involves many steps, fr...

Luxiga Thanabalachandran, D. Ali, Avery Newman-Simmons et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.